Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Cholangiocarcinoma × Albumin-Bound Paclitaxel × Clear all

Phase

Phase 2 6 Phase 1 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Neoplasms 1 Cholangiocarcinoma 1

Interventions

Gemcitabine 4 Cisplatin 4 pembrolizumab 2 Photochemotherapy 2 futibatinib 1 Taxes 1 Radiofrequency Ablation 1 Paclitaxel 1 Neoadjuvant Therapy 1 Lasers 1 Fulvestrant 1 Drug Therapy 1 Capecitabine 1 Albumin-Bound Paclitaxel 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06037980 2025-02-17

PURITY

Gruppo Oncologico del Nord-Ovest

Phase 2/3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡